3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid has been researched along with uric acid in 1 studies
*Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN. [MeSH]
*Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN. [MeSH]
| Studies (3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid) | Trials (3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid) | Recent Studies (post-2010) (3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid) | Studies (uric acid) | Trials (uric acid) | Recent Studies (post-2010) (uric acid) |
|---|---|---|---|---|---|
| 36 | 1 | 1 | 27,980 | 1,717 | 9,982 |
| Protein | Taxonomy | 3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid (IC50) | uric acid (IC50) |
|---|---|---|---|
| Solute carrier family 2, facilitated glucose transporter member 9 | Homo sapiens (human) | 300 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirschhorn, WL; Meidl, E; Morgan, JM; Piraino, AJ; Saris, SD; Schaffer, AV | 1 |
1 trial(s) available for 3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid and uric acid
| Article | Year |
|---|---|
Uricosuric effect of CGS-12970, a new thromboxane synthase inhibitor.
Topics: Adolescent; Adult; Animals; Cattle; Creatinine; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Male; Middle Aged; Pyridines; Reference Values; Single-Blind Method; Thromboxane-A Synthase; Uric Acid; Uricosuric Agents; Xanthine Oxidase | 1993 |